Cited in 1 publication.
The Rabbit Polyclonal anti-MLLT1 antibody (Clone RB1927-1928) (ABIN390126) specifically detects MLLT1 in WB.
The antibody is reactive with Human samples.
MLLT1
(MLLT1, super elongation complex subunit (MLLT1))
Reactivity
Human
Host
Rabbit
Clonality
Polyclonal
Conjugate
This MLLT1 antibody is un-conjugated
Application
Western Blotting (WB)
Clone
RB1927-1928
Binding Specificity
AA 523-552, C-Term
Purification
This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This MLLT1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 523-552 amino acids from the C-terminal region of human MLLT1.
MLLT1
Reactivity: Human
WB, ELISA
Host: Rabbit
Polyclonal
unconjugated
Application Notes
WB: 1:2000. WB: 1:2000. WB: 1:1000
Restrictions
For Research Use only
Format
Liquid
Buffer
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
Expiry Date
6 months
Bitoun, Oliver, Davies: "The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling." in: Human molecular genetics, Vol. 16, Issue 1, pp. 92-106, (2007) (PubMed).
Target
MLLT1
(MLLT1, super elongation complex subunit (MLLT1))
Alternative Name
MLLT1
Background
Chromosome band 11q23 is the site of translocations in myeloid and lymphoid acute leukemias, pediatric leukemias, and treatment-induced secondary acute myelogenous leukemia. The translocation breakpoints cluster in a restricted region of the HRX gene resulting in chimeric genes that encode an N-terminal portion of Hrx fused to various partner proteins. Myeloid/lymphoid or mixed-lineage leukemia translocated to 1 (MLLT1) is a nuclear protein with transcriptional transactivation properties that is fused to Hrx in t(11,19) leukemias. The minimal MLLT1 sequence required for transcription activation was narrowed to the C-terminal 90 amino acids.